INCREASED NEOPTERIN AND INTERFERON-GAMMA SECRETION AND LOWER AVAILABILITY OF L-TRYPTOPHAN IN MAJOR DEPRESSION - FURTHER EVIDENCE FOR AN IMMUNE-RESPONSE

被引:250
作者
MAES, M
SCHARPE, S
MELTZER, HY
OKAYLI, G
BOSMANS, E
DHONDT, P
VANDEN BOSSCHE, B
COSYNS, P
机构
[1] UNIV CLEVELAND HOSP, CLEVELAND, OH 44106 USA
[2] EUROGENET, TESSENDERLO, BELGIUM
[3] UNIV ANTWERP HOSP, ANTWERP, BELGIUM
关键词
AFFECTIVE DISORDER; PTERIDINES; CYTOKINES; SEROTONIN; PSYCHONEUROIMMUNOLOGY;
D O I
10.1016/0165-1781(94)90003-5
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
There is now some evidence that major depression may be accompanied by an immune response. The latter condition is suggested by elevated secretion of neopterin and interferon-gamma (IFN gamma) and by lower L-tryptophan (L-TRP) plasma levels. This study investigated the plasma levels of neopterin, L-TRP, and the L-TRP/competing amino acids (CAA) ratio in 30 normal control subjects and 47 depressed subjects (16 minor depressed, 13 simple major depressed, and 18 melancholic subjects), and IFN gamma secretion by mitogen-stimulated peripheral blood mononuclear cells in 7 normal control subjects and 13 major depressed subjects. Plasma neopterin levels were significantly higher in depressed subjects than in normal controls; 61% of melancholic patients had increased neopterin levels (greater than or equal to 7 nmol/l) with a specificity of 90%. Patients with major depression had significantly lower L-TRP and L-TRP/CAA values compared with normal control subjects. The amino acid values were significantly and negatively correlated with plasma neopterin levels. Major depressed subjects exhibited significantly higher IFN gamma secretion than did normal control subjects. The results further support the hypothesis that major depression is accompanied by an immune response and that the lower L-TRP availability in that illness may be an epiphenomenon of immune activation.
引用
收藏
页码:143 / 160
页数:18
相关论文
共 86 条
  • [1] ON THE CLINICAL RELEVANCE OF PSYCHONEUROIMMUNOLOGY
    ADER, R
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1992, 64 (01): : 6 - 8
  • [2] Ader R., 1991, PSYCHONEUROIMMUNOLOG
  • [3] A CONTROLLED-STUDY OF CELLULAR IMMUNE FUNCTION IN AFFECTIVE-DISORDERS BEFORE AND DURING SOMATIC THERAPY
    ALBRECHT, J
    HELDERMAN, JH
    SCHLESSER, MA
    RUSH, AJ
    [J]. PSYCHIATRY RESEARCH, 1985, 15 (03) : 185 - 193
  • [4] Asnis G.M., 1989, DEPRESSIVE DISORDERS, P51
  • [5] AUKRUST P, 1992, CLIN EXP IMMUNOL, V89, P211
  • [6] AUZEBY A, 1988, CLIN CHEM, V34, P1866
  • [7] Auzeby A., 1989, PTERIDINES, V1, P17, DOI [10.1515/pteridines.1989.1.1.17, DOI 10.1515/PTERIDINES.1989.1.1.17]
  • [8] BLACKBURN GL, 1979, SURGERY, V86, P307
  • [9] BROWN RR, 1989, CANCER RES, V49, P4941
  • [10] BURNS DN, 1991, J ACQ IMMUN DEF SYND, V4, P76